Apoptosis is reduced in the colonic mucosa of patients with acromegaly

Fausto Bogazzi1, Dania Russo, Maria Teresa Locci

  • 1Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy. f.bogazzi@endoc.med.unipi.it

Clinical Endocrinology
|December 14, 2005
PubMed
Abstract

Insights

Patients with active acromegaly show reduced apoptosis in colon cells, a condition reversed upon treatment. This suggests decreased apoptosis may be an early step in colon tumor development for acromegaly patients.

Area of Science:

  • Endocrinology
  • Gastroenterology
  • Oncology

Background:

  • Acromegaly increases colon tumor risk, with reduced apoptosis a suspected mechanism.
  • While growth hormone (GH) and insulin-like growth factor-1 (IGF-1) reduce apoptosis in cell lines, its role in acromegaly patients' colonic mucosa was unclear.

Purpose of the Study:

  • To evaluate apoptosis levels in colonic mucosa from acromegaly patients.
  • To investigate the relationship between apoptosis, disease activity, and relevant molecular markers.

Main Methods:

  • Cross-sectional study involving 11 untreated acromegaly patients, 16 in remission, and 23 controls.
  • Colonic mucosa samples collected during colonoscopy.
  • Apoptosis assessed via DNA fragmentation or terminal deoxynucleotidyl transferase assay; PPARgamma and Bax expression analyzed.

Main Results:

  • Significantly reduced apoptosis (39.0%) in untreated acromegaly patients compared to controls (60.0%) and those in remission (62.0%).
  • Apoptosis inversely correlated with serum IGF-1 and GH levels.
  • Lower PPARgamma expression and reduced anti-apoptotic Bax protein observed in untreated patients.

Conclusions:

  • Untreated acromegaly patients exhibit reduced colonic mucosal apoptosis, which normalizes after treatment.
  • Decreased apoptosis may be an early event in colonic tumorigenesis associated with acromegaly.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Adaptation I: Introduction and Atrophy01:23

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...